Henlez

About:

Henlez provides biologic solutions to manage recurrent and follicular skin disorders.

Top Investors: EIR Ventures, Karolinska

Description:

Henlez uses precise enzymes to create disruptive topical treatments for recurrent follicular skin problems. The company can be reached via mail, phone, or physical address.

Total Funding Amount:

1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2019-01-01

Contact Email:

contact(AT)henlez.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-10-24

IPO Status:

Private

Industries: